Alimera Sciences (STU:ASZ1) Other Operating Expense : €10.31 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Alimera Sciences Other Operating Expense?

Alimera Sciences's Other Operating Expense for the three months ended in Mar. 2024 was €2.84 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €10.31 Mil.

Alimera Sciences's quarterly Other Operating Expense declined from Sep. 2023 (€2.96 Mil) to Dec. 2023 (€2.79 Mil) but then increased from Dec. 2023 (€2.79 Mil) to Mar. 2024 (€2.84 Mil).

Alimera Sciences's annual Other Operating Expense increased from Dec. 2021 (€2.28 Mil) to Dec. 2022 (€2.55 Mil) and increased from Dec. 2022 (€2.55 Mil) to Dec. 2023 (€8.02 Mil).

Alimera Sciences Other Operating Expense Historical Data

The historical data trend for Alimera Sciences's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alimera Sciences Other Operating Expense Chart

Alimera Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

2.38

2.20

2.28

2.55

8.02

Alimera Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															0.64	1.72	2.96	2.79	2.84

Alimera Sciences Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €10.31 Mil.

Alimera Sciences Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Alimera Sciences's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Alimera Sciences (STU:ASZ1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alimera Sciences Inc (STU:ASZ1) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

ALIM:USA ASZ1:Germany

Address

6310 Town Square, Suite 400, Alpharetta, GA, USA, 30005

Website

https://www.alimerasciences.com

Alimera Sciences Inc is a commercial-stage pharmaceutical company developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a leading cause of blindness, and outside the U.S. for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a sustained-release intravitreal implant that enables patients to maintain vision longer, and importantly, with fewer injections. The company commercializes ILUVIEN in the U.S., Europe, China and the Middle East.

Alimera Sciences (STU:ASZ1) Headlines

No Headlines